| 51.36 |  +1.24 / +2.47% |
Data as of 3:59pm ET | Day’s Change |
| 51.35 |  -0.01 / -0.02% |
Volume: 303.1K |
| Gilead's Entry Into Cancer Therapy 12:51pm / MotleyFool.com | Stock Market News for June 3, 2013 - Market News Jun 03 / Zacks.com |
| June 14th Options Now Available For Gilead Sciences 11:06am / TheStreet.com | ASCO '13 Live Blog: Prepping for Monday Trading Jun 03 / TheStreet.com |
| 3 Stocks to Get on Your Watchlist Jun 05 / MotleyFool.com | Gilead Sciences Inc (GILD): Today's Featured Health Care Laggard May 31 / TheStreet.com |
| Why Idenix Is Poised to Pull Back Jun 05 / MotleyFool.com | Gilead's Stribild Approved in the EU - Analyst Blog May 29 / Zacks.com |
| CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward Jun 04 / TheStreet.com | Biotech: it's back May 27 / FT.com |
| Previous close | 50.12 |
| Today’s open | 50.38 |
| Day’s range | 49.66 - 51.68 |
| Volume | 14,169,007 |
| Average volume (3 months) | 12,203,905 |
| Market cap | $76.5B |
| Dividend yield | -- |
| Earnings growth (last year) | -7.61% |
| Earnings growth (this year) | +0.70% |
| Earnings growth (next 5 years) | +29.00% |
| Revenue growth (last year) | +13.58% |
| P/E ratio | 28.7 |
| Price/Sales | 5.79 |
| Price/Book | 8.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen Inc | +2.89 | +3.05% |
| BIIBBiogen Idec Inc | +7.05 | +3.29% |
| BAXBaxter International... | +0.69 | +1.00% |
| LIFELife Technologies Co... | +0.22 | +0.30% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $9.6B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 26.96% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John C. Martin, PhD, MBA |
President & Chief Operating Officer John F. Milligan, PhD |
Corporate headquarters Foster City, California |
.
